カレントテラピー　34-11　サンプル page 27/32

このページは カレントテラピー　34-11　サンプル の電子ブックに掲載されている27ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　34-11　サンプル

Current Therapy 2016 Vol.34 No.11 77治療薬解説1117plementary Treatment for Metabolic Disorders. DiabetesMetab J 39：291-303, 201520） Yoo SR, Kim YJ, Park DY, et al：curvatus in combinationalter hepatic lipid metabolism and suppress diet -inducedobesity. Obesity（Silver Spring）21：2571-2578, 201321） Wu CC, Weng WL, Lai WL, et al：Effect of Lactobacillusplantarum Strain K21 on High-Fat Diet-Fed Obese Mice.Evid Based Complement Alternat Med 2015：391767, 201522） Stenman LK, Waget A, Garret C, et al：Potential probioticBifidobacterium animalis ssp. lactis 420 prevents weight gainand glucose intolerance in diet-induced obese mice. BenefMicrobes 5：437-445, 201423） Kang JH, Yun SI, Park MH, et al：Anti -obesity effect ofLactobacillus gasseri BNR17 in high-sucrose diet-inducedobese mice. PLoS One 8：e54617, 201324） Everard A, Matamoros S, Geurts L, et al：Saccharomycesboulardii administration changes gut microbiota and reduceshepatic steatosis, low -grade inflammation, and fat massin obese and type 2 diabetic db/db mice. MBio 5：e01011-e01014, 201425） Wang J, Tang H, Zhang C, et al：Modulation of gut microbiotaduring probiotic -mediated attenuation of metabolic syndromein high fat diet-fed mice. ISME J 9：1-15, 201526） Gibson GR, Roberfroid MB：Dietary modulation of thehuman colonic microbiota：introducing the concept of prebiotics.J Nutr 125：1401-1412, 199527） Isawa K, Hojo K, Yoda N, et al：Isolation and identification ofa new bifidogenic growth stimulator produced by Propionibacteriumfreudenreichii ET-3. Biosci Biotechnol Biochem66：679-681, 200228） Yasuda A, Inoue KI, Sanbongi C, et al：Dietary supplementationwith fructooligosaccharides attenuates airway inflammationrelated to house dust mite allergen in mice. Int J lmmunopatholPharmacol 23：727-735, 201029） Ohta A, Motohashi Y, Sakai K, et al：Dietary fructooligosaccharidesincrease calcium absorption and levels of mucosalcalbindin-D9k in the large intestine of gastrectomized rats.Scand J Gastroenterol 33：1062-1068, 199830） Younes H, Garleb K, Behr S, et al：Fermentable fibers or oligosaccharidesreduce urinary nitrogen excretion by increasingurea disposal in the rat cecum. J Nutr 125：1010-1016, 199531） Videla S, Vilaseca J, Antolin M, et al：Dietary inulin improvesdistal colitis induced by dextran sodium sulfate in the rat. AmJ Gastroenterol 96：1486-1493, 200132） Camuesco D, Peran L, Comalada M, et al：Preventative effectsof lactulose in the trinitrobenzenesulphonic acid model of ratcolitis. Inflamm Bowel Dis 11：265-271, 200533） Lindsay JO, Whelan K, Stagg AJ, et al：Clinical, microbiological,and immunological effects of fructo -oligosaccharide inpatients with Crohn’s disease. Gut 55：348-355, 200634） Benjamin JL, Hedin CR, Koutsoumpas A, et al：Randomised,double-blind, placebo-controlled trial of fructo-oligosaccharidesin active Crohn’s disease. Gut 60：923-929, 201135） Mitsuyama K, Saiki T, Kanauchi O, et al：Treatment ofulcerative colitis with germinated barley foodstuff feeding：apilot study. Aliment Pharmacol Ther 12：1225-1230, 199836） Bamba T, Kanauchi O, Andoh A, et al：A new prebiotic fromgerminated barley for nutraceutical treatment of ulcerativecolitis. J Gastroenterol Hepatol 17：818-824, 200237） Casellas F, Borruel N, Torrejon A, et al：Oral oligofructoseenrichedinulin supplementation in acute ulcerative colitis iswell tolerated and associated with lowered faecal calprotectin.Aliment Pharmacol Ther 25：1061-1067, 200738） Okada Y, Tsuzuki Y, Miyazaki J, et al：Propionibacteriumfreudenreichii component 1.4-dihydroxy-2-naphthoic acid（DHNA）attenuates dextran sodium sulphate induced colitisby modulation of bacterial flora and lymphocyte homing. Gut55：681-688, 200639） Rowland IR, Rumney CJ, Coutts JT, et al：Effect of Bifidobacteriumlongum and inulin on gut bacterial metabolismand carcinogen-induced aberrant crypt foci in rats. Carcinogenesis19：281-285, 199840） Jan G, Belzacq AS, Haouzi D, et al：Propionibacteria induceapoptosis of colorectal carcinoma cells via short-chain fattyacids acting on mitochondria. Cell Death Differ 9：179-188,200241） Scott KP, Gratz SW, Sheridan PO, et al：The influence ofdiet on the gut microbiota. Pharmacol Res 69：52-60, 201242） Hosseini E, Grootaert C, Verstraete W, et al：Propionate as ahealth -promoting microbial metabolite in the human gut.Nutr Rev 69：245-258, 201143） Scholz-Ahrens KE, Schaafsma G, van den Heuvel EG, et al：Effects of prebiotics on mineral metabolism. Am J Clin Nutr73（2 Suppl）：459S-464S, 200144） Gopalakrishnan A, Clinthorne JF, Rondini EA, et al：Supplementationwith galacto-oligosaccharides increases the percentageof NK cells and reduces colitis severity in Smad3-deficientmice. J Nutr 142：1336-1342, 201245） Olesen M, Gudmand-Hoyer E：Efficacy, safety, and tolerabilityof fructooligosaccharides in the treatment of irritable bowelsyndrome. Am J Clin Nutr 72：1570-1575, 200046） Silk DB, Davis A, Vulevic J, et al：Clinical trial：the effectsof a trans-galactooligosaccharide prebiotic on faecal microbiotaand symptoms in irritable bowel syndrome. AlimentPharmacol Ther 29：508-518, 200947） Kaji l, Karaki S, Tanaka R, et al：Density distribution offree fatty acid receptor 2 （FFA2）-expressing and GLP-1-producing enteroendocrine L cells in human and rat lowerintestine, and increased cell numbers after ingestion of fructooligosaccharide.J Mol Histol 42：27-38, 201148） Cani PD, Possemiers S, Van de Wiele T, et al：Changes ingut microbiota control inflammation in obese mice through amechanism involving GLP -2-driven improvement of gutpermeability. Gut 58：1091-1103, 200949） Ide T, Moriuchi H, Nihimoto K：Hypolipidemic effectsof guar gum and its enzyme hydrolysate in rats fed highlysaturated fat diets. Ann Nutr Metab 35：34-44, 199150） Fujiya M, Musch MW, Nakagawa Y, et al：The Bacillus subtilisquorum-sensing molecule CSF contributes to intestinalhomeostasis via OCTN2, a host cell membrane transporter.Cell Host Microbe 1：299-308, 200751） Segawa S, Fujiya M, Konishi H, et al：Probiotic -derivedpolyphosphate enhances the epithelial barrier function andmaintains intestinal homeostasis through integrin -p38MAPK pathway. PloS One 6：e23278, 201152） Konishi H, Fujiya M, Tanaka H, et al：Probiotic-derived ferrichromeinhibits colon cancer progression via JNK-mediatedapoptosis. Nat Commun 7：12365, 2016